Ipca Labs. (IPCALAB)

FAST GROWER

FairStock Score: 54/100 — MIXED

Score breakdown: P/E: 0/3 · ROCE: 1/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Current Price₹1,522.95
Market Cap₹38,788.84 Cr
P/E Ratio36.73
ROCE14.72%
ROE13.09%
Dividend Yield0.26%
Profit Growth24.73%
Debt/Equity0.17
Sales Growth8.92%
Free Cash Flow₹45,100 Cr
Promoter Holding44.72%
52-Week Range₹1,251.6 — ₹1,679.45
SectorPharmaceuticals & Biotechnology
Book Value₹273.88

Ipca Labs. trades with a P/E ratio of 36.73, ROCE of 14.72%, ROE of 13.09%, profit growth of 24.73%, debt-to-equity of 0.17. The FairStock Score of 54/100 suggests mixed fundamentals — some metrics look solid while others need improvement.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer